{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:56:59Z","timestamp":1782892619800,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fort\u00fcne Project grant of the Medical Faculty of the University of T\u00fcbingen","award":["Nr.2253-0-0"],"award-info":[{"award-number":["Nr.2253-0-0"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5946-0","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:20:41Z","timestamp":1565259641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women"],"prefix":"10.1186","volume":"19","author":[{"given":"Ilnaz","family":"Sepahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Grundman-Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ossowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Susak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymonda","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelin","family":"Schr\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Niederacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Auber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hahnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Dworniczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang-Gorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gehrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard H. F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes R.","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hartkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-0236","authenticated-orcid":false,"given":"Christopher","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"5946_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"5946_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00439-008-0529-1","volume":"124","author":"PM Campeau","year":"2008","unstructured":"Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124:31\u201342.","journal-title":"Hum Genet"},{"key":"5946_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal P, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (80-. ). 1994;266:66\u201371 American Association for the Advancement of Science.","journal-title":"Science (80-. )"},{"key":"5946_CR4","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"R Wooster","year":"1994","unstructured":"Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (80-. ). 1994;265:2088\u201390.","journal-title":"Science (80-. )"},{"key":"5946_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789\u201392.","journal-title":"Nature"},{"key":"5946_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2012","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2012;12:68\u201378.","journal-title":"Nat Rev Cancer"},{"key":"5946_CR7","doi-asserted-by":"publisher","first-page":"465 LP","DOI":"10.1136\/jmedgenet-2015-103672","volume":"53","author":"K Kast","year":"2016","unstructured":"Kast K, Rhiem K, Wappenschmidt B, Hahnen E, Hauke J, Bluemcke B, et al. Prevalence of BRCA1\/2 germline mutations in 21 401 families with breast and ovarian cancer. J Med Genet. 2016;53:465 LP\u2013471.","journal-title":"J Med Genet"},{"key":"5946_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrc.2016.72","volume":"16","author":"FC Nielsen","year":"2016","unstructured":"Nielsen FC, van Overeem HT, S\u00f8rensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer. 2016;16:599\u2013612.","journal-title":"Nat Rev Cancer"},{"key":"5946_CR9","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402.","journal-title":"JAMA"},{"key":"5946_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"5946_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10552-005-1724-1","volume":"16","author":"J Kotsopoulos","year":"2005","unstructured":"Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control. 2005;16:667\u201374.","journal-title":"Cancer Causes Control"},{"key":"5946_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1002\/ijc.21273","volume":"117","author":"CA Cullinane","year":"2005","unstructured":"Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1\/BRCA2 mutation carriers. Int J Cancer. 2005;117:988\u201391 Wiley Subscription Services, Inc., A Wiley Company.","journal-title":"Int J Cancer"},{"key":"5946_CR13","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr1387","volume":"8","author":"E Friedman","year":"2006","unstructured":"Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, et al. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCAmutation carriers. Breast Cancer Res. 2006;8:R15.","journal-title":"Breast Cancer Res"},{"key":"5946_CR14","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1038\/sj.onc.1209870","volume":"25","author":"SA Narod","year":"2006","unstructured":"Narod SA. Modifiers of risk of hereditary breast cancer. Oncogene. 2006;25:5832\u20136.","journal-title":"Oncogene"},{"key":"5946_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609\u201315.","journal-title":"N Engl J Med"},{"key":"5946_CR16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van\u2019t Veer L, Garber JE, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med. 2002;346:1616\u201322.","journal-title":"N Engl J Med"},{"key":"5946_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-017-4325-2","volume":"165","author":"HR Brewer","year":"2017","unstructured":"Brewer HR, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Family history and risk of breast cancer: an analysis accounting for family structure. Breast Cancer Res Treat. 2017;165:193\u2013200 Springer.","journal-title":"Breast Cancer Res Treat"},{"key":"5946_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrc726","volume":"2","author":"SA Narod","year":"2002","unstructured":"Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002;2:113\u201323.","journal-title":"Nat Rev Cancer"},{"key":"5946_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet. 2001;68:410\u20139.","journal-title":"Am J Hum Genet"},{"key":"5946_CR20","first-page":"329","volume":"11","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton D. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomark Prev. 2002;11:329\u201336.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5946_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA. 2015;313:1347\u201361 NIH Public Access.","journal-title":"JAMA"},{"key":"5946_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ng1295-428","volume":"11","author":"SA Gayther","year":"1995","unstructured":"Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet. 1995;11:428\u201333.","journal-title":"Nat Genet"},{"issue":"Suppl 1","key":"5946_CR23","doi-asserted-by":"publisher","first-page":"i11","DOI":"10.1093\/annonc\/mdq660","volume":"22","author":"RL Milne","year":"2011","unstructured":"Milne RL, Antoniou AC. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol. 2011;22(Suppl 1):i11\u20137.","journal-title":"Ann Oncol"},{"key":"5946_CR24","doi-asserted-by":"publisher","first-page":"e1003173","DOI":"10.1371\/journal.pgen.1003173","volume":"9","author":"MM Gaudet","year":"2013","unstructured":"Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet. 2013;9:e1003173.","journal-title":"PLoS Genet"},{"key":"5946_CR25","doi-asserted-by":"publisher","first-page":"e1003212","DOI":"10.1371\/journal.pgen.1003212","volume":"9","author":"FJ Couch","year":"2013","unstructured":"Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet. 2013;9:e1003212 Hunter KW, editor. Public Library of Science.","journal-title":"PLoS Genet"},{"key":"5946_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ng.2566","volume":"45","author":"SE Bojesen","year":"2013","unstructured":"Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013;45:371\u201384 384e1-2.","journal-title":"Nat Genet"},{"key":"5946_CR27","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1093\/hmg\/ddp372","volume":"18","author":"AC Antoniou","year":"2009","unstructured":"Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet. 2009;18:4442\u201356.","journal-title":"Hum Mol Genet"},{"key":"5946_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajhg.2008.02.008","volume":"82","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008;82:937\u201348.","journal-title":"Am J Hum Genet"},{"key":"5946_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/ng.669","volume":"42","author":"AC Antoniou","year":"2010","unstructured":"Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet. 2010;42:885\u201392.","journal-title":"Nat Genet"},{"key":"5946_CR30","doi-asserted-by":"publisher","unstructured":"Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, Ausems MG, Collee JM, van Doorn HC, et al. Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst. 2015:107. Oxford University Press. \n                    https:\/\/doi.org\/10.1093\/jnci\/djv033\n                    \n                  .","DOI":"10.1093\/jnci\/djv033"},{"key":"5946_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12859-016-1069-7","volume":"17","author":"M Sturm","year":"2016","unstructured":"Sturm M, Schroeder C, Bauer P. SeqPurge: highly-sensitive adapter trimming for paired-end NGS data. BMC Bioinformatics. 2016;17:208 BioMed Central.","journal-title":"BMC Bioinformatics"},{"key":"5946_CR32","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short-read alignment with burrows-wheeler transform. Bioinformatics. 2009;25:1754\u201360 Oxford University Press.","journal-title":"Bioinformatics"},{"key":"5946_CR33","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/bioinformatics\/btu376","volume":"30","author":"LE Mose","year":"2014","unstructured":"Mose LE, Wilkerson MD, Hayes DN, Perou CM, Parker JS. ABRA: improved coding indel detection via assembly-based realignment. Bioinformatics. 2014;30:2813\u20135 Oxford University Press.","journal-title":"Bioinformatics"},{"key":"5946_CR34","volume-title":"Haplotype-based variant detection from short-read sequencing","author":"E Garrison","year":"2012","unstructured":"Garrison E, Marth G. Haplotype-based variant detection from short-read sequencing; 2012."},{"key":"5946_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 2012;6:80\u201392 Taylor & Francis.","journal-title":"Fly (Austin)"},{"key":"5946_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323 American College of Medical Genetics and Genomics.","journal-title":"Genet Med"},{"key":"5946_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg775","volume":"3","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002;3:285\u201398.","journal-title":"Nat Rev Genet"},{"key":"5946_CR38","doi-asserted-by":"crossref","unstructured":"Mayakonda A, Koeffler HP. Maftools: efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies. bioRxiv. 2016.","DOI":"10.1101\/052662"},{"key":"5946_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/ng1096-185","volume":"14","author":"B Roa","year":"1996","unstructured":"Roa B, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996;14:185\u20137.","journal-title":"Nat Genet"},{"key":"5946_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R. Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J. 2010;1:397\u2013412 Dordrecht: Springer Netherlands.","journal-title":"EPMA J"},{"key":"5946_CR41","doi-asserted-by":"publisher","unstructured":"Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J, et al. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2017;109. Oxford University Press. \n                    https:\/\/doi.org\/10.1093\/jnci\/djw302\n                    \n                  .","DOI":"10.1093\/jnci\/djw302"},{"key":"5946_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2014.06.009","volume":"95","author":"S Lee","year":"2014","unstructured":"Lee S, Abecasis GR, Boehnke M, Lin X. Rare-variant association analysis: study designs and statistical tests. Am J Hum Genet. 2014;95:5\u201323 Elsevier.","journal-title":"Am J Hum Genet"},{"key":"5946_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","volume":"49","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, et al. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet. 2012;49:525\u201332 BMJ Publishing Group Ltd.","journal-title":"J Med Genet"},{"key":"5946_CR44","first-page":"15","volume":"1","author":"S Moghadasi","year":"2017","unstructured":"Moghadasi S, Meeks HD, Vreeswijk MP, Janssen LA, Borg \u00c5, Ehrencrona H, et al. The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium. J Med Genet. 2017;1:15\u201320 BMJ Publishing Group Ltd.","journal-title":"J Med Genet"},{"key":"5946_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016;375:443\u201353.","journal-title":"N Engl J Med"},{"key":"5946_CR46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/gim.2016.206","volume":"19","author":"AS Brohl","year":"2017","unstructured":"Brohl AS, Patidar R, Turner CE, Wen X, Song YK, Wei JS, et al. Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma germline mutations in Ewing sarcoma. Genet Med. 2017;19:955\u20138.","journal-title":"Genet Med"},{"key":"5946_CR47","doi-asserted-by":"publisher","first-page":"21447","DOI":"10.1074\/jbc.273.34.21447","volume":"273","author":"KM Trujillo","year":"1998","unstructured":"Trujillo KM, Yuan SSF, Lee EYHP, Sung P. Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J Biol Chem. 1998;273:21447\u201350.","journal-title":"J Biol Chem"},{"key":"5946_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrm805","volume":"3","author":"D D\u2019Amours","year":"2002","unstructured":"D\u2019Amours D, Jackson SP. The MRE11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat Rev Mol Cell Biol. 2002;3:317\u201327 Nature Publishing Group.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5946_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/nature05740","volume":"447","author":"TH Stracker","year":"2007","unstructured":"Stracker TH, Morales M, Couto SS, Hussein H, Petrini JHJ. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature. 2007;447:218\u201321.","journal-title":"Nature"},{"key":"5946_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature03442","volume":"434","author":"J Falck","year":"2005","unstructured":"Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature. 2005;434:605\u201311.","journal-title":"Nature"},{"key":"5946_CR51","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(00)81547-0","volume":"99","author":"GS Stewart","year":"1999","unstructured":"Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 1999;99:577\u201387.","journal-title":"Cell"},{"key":"5946_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0092-8674(00)81174-5","volume":"93","author":"R Varon","year":"1998","unstructured":"Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998;93:467\u201376 Cell Press.","journal-title":"Cell"},{"key":"5946_CR53","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.ijrobp.2016.06.115","volume":"96","author":"GP Gupta","year":"2017","unstructured":"Gupta GP, Ho AY, Feng W, Fan C, Akram M, Brogi E, et al. Mre11 dysfunction is associated with triple-negative breast cancer and confers sensitivity to DNA damaging therapy. Int J Radiat Oncol Biol Phys. 2017;96:S43 Elsevier.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5946_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-2407-13-65","volume":"13","author":"K Akaogi","year":"2013","unstructured":"Akaogi K, Ono W, Hayashi Y, Kishimoto H, Yanagisawa J. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis. BMC Cancer. 2013;13:65 BioMed Central.","journal-title":"BMC Cancer"},{"key":"5946_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1023\/A:1008340723974","volume":"11","author":"WD Foulkes","year":"2000","unstructured":"Foulkes WD, Chappuis PO, Wong N, Brunet J-S, Vesprini D, Rozen F, et al. Primary node negative breast cancer in BRCAI mutation carriers has a poor outcome. Ann Oncol. 2000;11:307\u201313 Oxford University Press.","journal-title":"Ann Oncol"},{"key":"5946_CR56","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2200::AID-CNCR14>3.0.CO;2-S","volume":"85","author":"S Noguchi","year":"1999","unstructured":"Noguchi S, Kasugai T, Miki Y, Fukutomi T, Emi M, Nomizu T. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women. Cancer. 1999;85:2200\u20135 John Wiley & Sons, Inc.","journal-title":"Cancer"},{"key":"5946_CR57","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W","volume":"83","author":"N Loman","year":"1998","unstructured":"Loman N, Johannsson O, Bendahl P-O, Borg \u00c5, Fern\u00f6 M, Olsson H. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer. 1998;83:310\u20139 John Wiley & Sons, Inc.","journal-title":"Cancer"},{"key":"5946_CR58","unstructured":"Vaziri SAJ, Krumroy LM, Elson P, Budd GT, Darlington G, Myles J, et al. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis. Clin Cancer Res. 2001;7:1937 LP\u20131945."},{"key":"5946_CR59","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1186\/bcr1025","volume":"7","author":"H Eerola","year":"2005","unstructured":"Eerola H, Heikkil\u00e4 P, Tamminen A, Aittom\u00e4ki K, Blomqvist C, Nevanlinna H. Relationship of patients\u2019 age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families. Breast Cancer Res. 2005;7:R465.","journal-title":"Breast Cancer Res"},{"key":"5946_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/302320","volume":"64","author":"P Hartge","year":"1999","unstructured":"Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet. 1999;64:963\u201370.","journal-title":"Am J Hum Genet"},{"key":"5946_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa070608","volume":"357","author":"G Rennert","year":"2007","unstructured":"Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, et al. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med. 2007;357:115\u201323 Massachusetts Medical Society.","journal-title":"N Engl J Med"},{"key":"5946_CR62","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/annonc\/mdq460","volume":"22","author":"O Lavie","year":"2011","unstructured":"Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O, et al. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol. 2011;22:964\u20136 Oxford University Press.","journal-title":"Ann Oncol"},{"key":"5946_CR63","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10549-012-2050-4","volume":"134","author":"S Heidemann","year":"2012","unstructured":"Heidemann S, Fischer C, Engel C, Fischer B, Harder L, Schlegelberger B, et al. Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat. 2012;134:1229\u201339.","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5946-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T23:11:00Z","timestamp":1596755460000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5946"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5946-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of the Medical faculty of the Eberhard-Karls University and the University Hospital of T\u00fcbingen (project number 053\/2017BO2). Members of the committee were: Prof. Dr. med Henner Giedke, Prof. Dr. med J\u00fcrgen Honegger, Prof. Dr. med. Holger Lerche, Prof. Dr. med. Dieter Luft, Prof. Dr. med. Klaus M\u00f6rike, Prof. Dr. med. Christian F. Poets, Prof. Dr. iur. Dr. h.c. Georg Sandberger, Prof. Dr. Dr. Siegmar Reinert, Prof. Dr. med. Dr. phil. Urban Wiesing. All participants signed a written informed consent before study enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"787"}}